Literature DB >> 9220027

Overexpression of glucagon-like peptide-1 receptor in an insulin-secreting cell line enhances glucose responsiveness.

C Montrose-Rafizadeh1, Y Wang, A M Janczewski, T E Henderson, J M Egan.   

Abstract

Glucagon-like peptide-1 (GLP-1), secreted from intestine in response to food intake, enhances insulin secretion from pancreatic beta-cells. In this study, we evaluated the effects of stably transfecting the GLP-1 receptor into an insulinoma cell line, RIN 1046-38, on basal and glucose-mediated insulin secretion and on second messenger pathways involved in insulin secretion. The GLP-1 receptor transfected cells had similar insulin mRNA levels but higher insulin content compared with parental cells. In GLP-1 receptor transfected cells, glucose (0.5 mM)-mediated insulin release was increased compared with parental cells (4.52 +/- 0.79 pmol insulin/l per mg protein x h vs. 2.21 +/- 0.36 pmol insulin/l per mg protein x h; mean +/- S.E., n = 6, P = 0.015, in transfected vs. parental cells, respectively). By hemolytic plaque assay measuring single cell insulin secretion, we observed that in the GLP-1 receptor transfected cells versus parental cells the increased insulin secretion was due to the presence of more glucose-responsive cells as well as more insulin released in response to glucose per cell. Resting intracellular cAMP was higher in the GLP-1 transfected cells (35.96 +/- 3.88 vs. 18.6 +/- 2.01 nmol/l per mg protein x h; mean +/- S.E., n = 4, P = 0.039, in transfected vs. parental cells, respectively). In response to GLP-1, both GLP-1 receptor transfected cells and parental cells showed increased cAMP levels independent of glucose. Resting intracellular calcium was the same in both parental and GLP-1 receptor transfected cells. However, more cells were responsive to glucose in the GLP-1 receptor transfected cells and the calcium transients attained in the presence of glucose developed at a faster rate and reached a higher amplitude than in parental cells. We conclude that having an excess of GLP-1 receptors renders beta-cells more sensitive to glucose.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220027     DOI: 10.1016/s0303-7207(97)00079-8

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

2.  Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation.

Authors:  Oleg G Chepurny; George G Holz
Journal:  Cell Tissue Res       Date:  2002-01-08       Impact factor: 5.249

Review 3.  Mechanisms of action of glucagon-like peptide 1 in the pancreas.

Authors:  Máire E Doyle; Josephine M Egan
Journal:  Pharmacol Ther       Date:  2006-12-28       Impact factor: 12.310

4.  Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications.

Authors:  Meike Körner; Emanuel Christ; Damian Wild; Jean Claude Reubi
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-06       Impact factor: 5.555

5.  Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.

Authors:  Jennifer L Fiori; Yu-Kyong Shin; Wook Kim; Susan M Krzysik-Walker; Isabel González-Mariscal; Olga D Carlson; Mitesh Sanghvi; Ruin Moaddel; Kathleen Farhang; Shekhar K Gadkaree; Maire E Doyle; Kevin J Pearson; Julie A Mattison; Rafael de Cabo; Josephine M Egan
Journal:  Diabetes       Date:  2013-07-24       Impact factor: 9.461

6.  Glucose and GLP-1 stimulate cAMP production via distinct adenylyl cyclases in INS-1E insulinoma cells.

Authors:  Lavoisier S Ramos; Jonathan Hale Zippin; Margarita Kamenetsky; Jochen Buck; Lonny R Levin
Journal:  J Gen Physiol       Date:  2008-08-11       Impact factor: 4.086

7.  Toxins in Drug Discovery and Pharmacology.

Authors:  Steve Peigneur; Jan Tytgat
Journal:  Toxins (Basel)       Date:  2018-03-16       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.